AR016481A1 - Preparaciones farmaceuticas que se desintegran oralmente que contienen sildenafilo - Google Patents

Preparaciones farmaceuticas que se desintegran oralmente que contienen sildenafilo

Info

Publication number
AR016481A1
AR016481A1 ARP990102274A ARP990102274A AR016481A1 AR 016481 A1 AR016481 A1 AR 016481A1 AR P990102274 A ARP990102274 A AR P990102274A AR P990102274 A ARP990102274 A AR P990102274A AR 016481 A1 AR016481 A1 AR 016481A1
Authority
AR
Argentina
Prior art keywords
sildenafilo
oralally
disintegrated
contain
pharmaceutical preparations
Prior art date
Application number
ARP990102274A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR016481A1 publication Critical patent/AR016481A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicon Polymers (AREA)

Abstract

Una preparacion farmacéutica que se desintegra oralmente que comprende la base libre de sildenafilo junto con un vehículo aceptable farmacéuticamente.
ARP990102274A 1998-05-15 1999-05-13 Preparaciones farmaceuticas que se desintegran oralmente que contienen sildenafilo AR016481A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8564698P 1998-05-15 1998-05-15

Publications (1)

Publication Number Publication Date
AR016481A1 true AR016481A1 (es) 2001-07-04

Family

ID=22193027

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102274A AR016481A1 (es) 1998-05-15 1999-05-13 Preparaciones farmaceuticas que se desintegran oralmente que contienen sildenafilo

Country Status (32)

Country Link
US (1) US20020002172A1 (es)
EP (1) EP0960621A3 (es)
JP (1) JPH11349483A (es)
KR (1) KR19990088249A (es)
CN (1) CN1251758A (es)
AP (1) AP9901534A0 (es)
AR (1) AR016481A1 (es)
AU (1) AU753478B2 (es)
BG (1) BG103396A (es)
BR (1) BR9902086A (es)
CA (1) CA2272042A1 (es)
CO (1) CO5060503A1 (es)
DZ (1) DZ2786A1 (es)
EA (1) EA002830B1 (es)
GT (1) GT199900061A (es)
HN (1) HN1999000066A (es)
HR (1) HRP990144A2 (es)
HU (1) HUP9901606A2 (es)
ID (1) ID23299A (es)
IS (1) IS5046A (es)
MA (1) MA26629A1 (es)
NO (1) NO992339L (es)
NZ (1) NZ335772A (es)
OA (1) OA11040A (es)
PA (1) PA8472901A1 (es)
PE (1) PE20000546A1 (es)
PL (1) PL333118A1 (es)
SG (1) SG79255A1 (es)
SK (1) SK61599A3 (es)
TR (1) TR199901077A3 (es)
YU (1) YU21999A (es)
ZA (1) ZA993338B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020033A1 (fr) * 1998-10-05 2000-04-13 Eisai Co., Ltd. Comprimes se delitant immediatement dans la cavite buccale
WO2000053148A2 (en) * 1999-03-08 2000-09-14 Merck & Co., Inc. Methods and compositions for treating erectile dysfunction
WO2000054777A1 (en) * 1999-03-16 2000-09-21 Pentech Pharmaceuticals, Inc. Controlled release of sildenafil delivered by sublingual or buccal administration
WO2000057857A1 (en) * 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
KR100344198B1 (ko) * 1999-10-08 2002-07-19 일양약품주식회사 실데나필 시트레이트의 속효제형
AU2001284444B2 (en) 2000-09-06 2006-05-25 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
IN192750B (es) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
EP1226818A1 (en) * 2001-01-26 2002-07-31 Pfizer Products Inc. Pharmaceutical dosage forms with enhanced cohesive and compressibility properties
JP4540295B2 (ja) * 2001-05-09 2010-09-08 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト ２−フェニル置換イミダゾトリアジノンの新しい用途
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
JPWO2003028706A1 (ja) * 2001-09-28 2005-01-13 株式会社三和化学研究所 有核型速溶崩壊性成型品
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
AU2003220808B2 (en) 2003-03-27 2008-08-21 Bioactis Limited Powder medicine applicator for nasal cavity
US20050042177A1 (en) * 2003-07-23 2005-02-24 Elan Pharma International Ltd. Novel compositions of sildenafil free base
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
JP4922762B2 (ja) * 2004-08-10 2012-04-25 株式会社新日本科学 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
CA2612917A1 (en) * 2005-06-23 2007-01-04 Schering Corporation Rapidly absorbing oral formulations of pde5 inhibitors
BRPI0616633A2 (pt) * 2005-09-29 2011-06-28 Bayer Healthcare Ag inibidores de pde e combinações dos mesmos para o tratamento de transtornos urológicos
ES2652415T3 (es) 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
EP2486921A1 (en) * 2007-02-12 2012-08-15 DMI Biosciences, Inc. Reducing Side Effects of Tramadol
US20100184769A1 (en) * 2007-06-13 2010-07-22 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
FR2932682B1 (fr) * 2008-06-23 2013-07-12 Bionetwork Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.
AU2010223105B2 (en) 2009-03-09 2016-05-12 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
JP2012526726A (ja) * 2009-05-15 2012-11-01 株式会社新日本科学 薬物動態が改善された鼻腔内用薬学的組成物
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
WO2011030351A2 (en) 2009-09-03 2011-03-17 Rubicon Research Private Limited Taste - masked pharmaceutical compositions
EP2338474A1 (de) * 2009-12-23 2011-06-29 Ratiopharm GmbH Oral dispersible Tablette enthaltend kompaktierte Sildenafil-Base
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
EA027720B1 (ru) * 2011-02-11 2017-08-31 СиТиСи БАЙО, ИНК. Способ получения пленки, содержащей свободное основание силденафила
KR101418406B1 (ko) * 2011-08-24 2014-07-10 한미약품 주식회사 실데나필 유리 염기를 포함하는 구강 붕해정
MX366768B (es) * 2011-12-08 2019-07-17 Laboratorios Liomont S A De C V Tableta orodispersable de sildenafil y metodo para preparar la misma.
KR102239291B1 (ko) 2013-06-28 2021-04-14 한미약품 주식회사 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
CN105769887B (zh) * 2014-12-23 2019-04-30 上海复星星泰医药科技有限公司 一种复方果糖二磷酸钠果糖口崩片及其制备方法
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN114246835A (zh) * 2022-01-05 2022-03-29 河北龙海药业有限公司 一种枸橼酸西地那非口腔崩解片的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
DE19532142A1 (de) * 1995-08-31 1997-03-06 Siemens Ag Verfahren und Vorrichtung zur Regelung eines vierdimensionalen Vektors einer Strecke mittels eines wertediskreten Stellgliedes mit begrenzter Schaltfrequenz
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations
CN1309561A (zh) * 1997-05-29 2001-08-22 持田制药株式会社 ***机能障碍治疗剂
TW542719B (en) * 1998-02-23 2003-07-21 Pfizer Res & Dev Method of treating impotence due to spinal cord injury
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
WO2000054777A1 (en) * 1999-03-16 2000-09-21 Pentech Pharmaceuticals, Inc. Controlled release of sildenafil delivered by sublingual or buccal administration

Also Published As

Publication number Publication date
HRP990144A2 (en) 2000-02-29
BG103396A (bg) 2000-01-31
HUP9901606A2 (en) 2002-09-28
TR199901077A2 (en) 1999-12-21
HN1999000066A (es) 1999-09-29
PE20000546A1 (es) 2000-07-07
MA26629A1 (fr) 2004-12-20
EA002830B1 (ru) 2002-10-31
AU2812699A (en) 1999-11-25
JPH11349483A (ja) 1999-12-21
TR199901077A3 (tr) 1999-12-21
NO992339L (no) 1999-11-16
BR9902086A (pt) 2000-05-02
KR19990088249A (ko) 1999-12-27
AU753478B2 (en) 2002-10-17
GT199900061A (es) 2000-10-14
NZ335772A (en) 2000-12-22
CA2272042A1 (en) 1999-11-15
PL333118A1 (en) 1999-11-22
HU9901606D0 (en) 1999-07-28
AP9901534A0 (en) 1999-06-30
OA11040A (en) 2003-01-01
EA199900373A3 (ru) 2000-08-28
EP0960621A2 (en) 1999-12-01
DZ2786A1 (fr) 2003-12-01
US20020002172A1 (en) 2002-01-03
NO992339D0 (no) 1999-05-14
ZA993338B (en) 2000-11-14
CN1251758A (zh) 2000-05-03
EA199900373A2 (ru) 1999-12-29
IS5046A (is) 1999-11-16
EP0960621A3 (en) 2000-01-05
SG79255A1 (en) 2001-03-20
SK61599A3 (en) 2000-12-11
PA8472901A1 (es) 2000-09-29
YU21999A (sh) 2002-03-18
CO5060503A1 (es) 2001-07-30
ID23299A (id) 2000-04-05

Similar Documents

Publication Publication Date Title
AR016481A1 (es) Preparaciones farmaceuticas que se desintegran oralmente que contienen sildenafilo
USD411311S (en) Public service structure
MX9203236A (es) Composicion farmaceutica que comprende una ciclosporina.
DE60010098D1 (de) 28-epirapaloge
SI1037607T1 (en) Novel suppository form comprising an acid-labile active compound
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
USD433600S (en) Bowl
AR021981A1 (es) Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero
EE200000438A (et) Farmatseutiliselt aktiivne morfolinool
IS5869A (is) Hraðlosandi tafla
ATE238812T1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
HK1048306A1 (en) Pharmaceutically active sulfonamide derivatives.
TR199902175T2 (xx) Parasetamol i�eren yutma tableti.
YU52999A (sh) Kombinacija analgetika
IT1294671B1 (it) Compressa di maleato di trimebutina rivestita con una pellicola.
USD460490S1 (en) Neon sign
NO20001415L (no) Farmasøytikum inneholdende vitamin-K-avhengige faktorer
MXPA02011935A (es) Guardapolvo.
USD444412S1 (en) Christmas tree stand
ATE298576T1 (de) Arzneizubereitungen
USD484916S1 (en) Neon sign
MX21453A (es) Preparaciones farmaceuticas que se administran en forma topica.
ES2191241T3 (es) Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina.
EA200000112A1 (ru) Новая композиция
AR019331A2 (es) Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal